Chemotherapy resistance of glioblastoma stem cells.
Eramo
A
A
Ricci-Vitiani
L
L
Zeuner
A
A
Pallini
R
R
Lotti
F
F
Sette
G
G
Pilozzi
E
E
Larocca
L M
LM
Peschle
C
C
De Maria
R
R
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D001932:Brain Neoplasms / Q000188:drug therapy / Q000473:pathology; D002945:Cisplatin / Q000494:pharmacology / Q000627:therapeutic use; D004317:Doxorubicin / Q000494:pharmacology / Q000627:therapeutic use; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D005047:Etoposide / Q000494:pharmacology / Q000627:therapeutic use; D005909:Glioblastoma / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D019169:Jurkat Cells; D051379:Mice; D008819:Mice, Nude; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000473:pathology; D013997:Time Factors; D014407:Tumor Cells, Cultured; D023041:Xenograft Model Antitumor Assays
D000970:Antineoplastic Agents; D005047:Etoposide; D004317:Doxorubicin; D002945:Cisplatin